Follow the people · Insider
Keyvan Samini
Keyvan Samini files insider transactions with the SEC as a president, cfo & director of Mobix Labs (MOBX). We hold 3 disclosed purchases and sales filed since 26 December 2023, 2 of them in the last 90 days.
- Files forMOBX
- Disclosed buys and sells3 in all, 2 in the last 90 days
- Last disclosure25 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 21 December 2023 — 21 August 2026President, CFO & Director · Mobix Labs (MOBX)19 Form 4 lines · source: SEC Form 4
Everything they disclosed
19 entries, newest first — one per disclosure report, one per Form 4 line- converted 12,500 shares of Mobix LabsSEC Form 425 August 2026Class A Common Stock · traded 21 August 2026 · filed 25 August 2026
- converted 12,500 shares of Mobix Labs (a derivative holding)SEC Form 425 August 2026Class B Common Stock · traded 21 August 2026 · filed 25 August 2026
- ▼ sold on the open market 3 shares of Mobix LabsSEC Form 415 June 2026Class A Common Stock · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 112,110 shares of Mobix LabsSEC Form 415 June 2026Class A Common Stock · traded 12 June 2026 · filed 15 June 2026
- exercised options over 333,333 shares of Mobix LabsSEC Form 47 January 2026Class A Common Stock · traded 21 December 2025 · filed 7 January 2026
- ▼ sold on the open market 211,672 shares of Mobix LabsSEC Form 47 January 2026Class A Common Stock · traded 5 January 2026 · filed 7 January 2026
- exercised options over 333,333 shares of Mobix Labs (a derivative holding)SEC Form 47 January 2026Restricted Stock Units · traded 21 December 2025 · filed 7 January 2026
- exercised options over 333,333 shares of Mobix Labs (a derivative holding)SEC Form 47 January 2026Restricted Stock Units · traded 21 December 2025 · filed 7 January 2026
- exercised options over 333,333 shares of Mobix LabsSEC Form 47 January 2026Class A Common Stock · traded 21 December 2025 · filed 7 January 2026
- ▼ sold on the open market 211,672 shares of Mobix LabsSEC Form 47 January 2026Class A Common Stock · traded 5 January 2026 · filed 7 January 2026
- was granted 915,033 shares of Mobix Labs (a derivative holding)SEC Form 413 August 2025Class B Common Stock · traded 30 May 2025 · filed 13 August 2025
- was granted 2,550,000 shares of Mobix LabsSEC Form 47 May 2025Class A Common Stock · traded 5 May 2025 · filed 7 May 2025
- was granted 333,333 shares of Mobix Labs (a derivative holding)SEC Form 417 April 2025Restricted Stock Units · traded 15 April 2025 · filed 17 April 2025
- was granted 318,029 shares of Mobix Labs (a derivative holding)SEC Form 427 February 2025Option (Right to Buy) · traded 21 December 2023 · filed 27 February 2025
- was granted 125,000 shares of Chavant Capital Acquisition (a derivative holding)SEC Form 426 December 2023Class B Common Stock · traded 21 December 2023 · filed 26 December 2023
- was granted 323,529 shares of Chavant Capital AcquisitionSEC Form 426 December 2023Class A Common Stock · traded 21 December 2023 · filed 26 December 2023
- was granted 73,529 shares of Chavant Capital AcquisitionSEC Form 426 December 2023Class A Common Stock · traded 21 December 2023 · filed 26 December 2023
- was granted 171,146 shares of Chavant Capital AcquisitionSEC Form 426 December 2023Class A Common Stock · traded 21 December 2023 · filed 26 December 2023
- was granted 73,529 shares of Chavant Capital AcquisitionSEC Form 426 December 2023Class A Common Stock · traded 21 December 2023 · filed 26 December 2023
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.